| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/01/2010 | CN1872050B Drop pills of silymarin, and preparation method |
| 12/01/2010 | CN1872045B Drop pills of lysionotin, and preparation method |
| 12/01/2010 | CN1872044B Medication for treating coronary heart disease |
| 12/01/2010 | CN1870983B Compositions and foods for improving lipid metabolism |
| 12/01/2010 | CN1863810B Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and uses as NMDA receptor antagnist |
| 12/01/2010 | CN1857237B New use of falcarindiol |
| 12/01/2010 | CN1853633B Use of beta-FNA in preparing medicine for dementia praecox treatment |
| 12/01/2010 | CN1852713B Polymorphic form of montelukast sodium |
| 12/01/2010 | CN1809584B Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof |
| 12/01/2010 | CN1806644B Fat or oil containing unsaturated fatty acid |
| 12/01/2010 | CN1787750B Hot liquid fiber product |
| 12/01/2010 | CN1785202B Medicinal composition for treating cardiovascular disease and its preparation method |
| 12/01/2010 | CN1780612B Treatment of incontinence with 5HT2C agonists. |
| 12/01/2010 | CN1778333B Chinese medicine for treating coronary heart disease and angina cordis |
| 12/01/2010 | CN1750817B Use of the (1s, 2r) enantiomer of milnacipran for the preparation of a drug |
| 12/01/2010 | CN1703205B Extended, controlled-release pharmaceutical compositions using charged polymers |
| 12/01/2010 | CN1694715B Use of beta glucan particles and antibodies in preparing medicine for cancer therapy |
| 12/01/2010 | CN1617703B Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof |
| 12/01/2010 | CN1520286B Gastric retention controlled drug delivery system |
| 12/01/2010 | CN101903396A Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
| 12/01/2010 | CN101903395A Compounds for inhibiting KSP kinesin activity |
| 12/01/2010 | CN101903392A Inhibitors of serine proteases |
| 12/01/2010 | CN101903389A Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 12/01/2010 | CN101903388A Spiroindolinone derivatives as anticancer agents |
| 12/01/2010 | CN101903387A 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 12/01/2010 | CN101903385A 4-aminopyrimidine derivatives as histamine H4 receptor antagonists |
| 12/01/2010 | CN101903384A [1h-pyrazolo [3, 4-b] pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase C-theta |
| 12/01/2010 | CN101903382A Heterocyclic antiviral compounds |
| 12/01/2010 | CN101903380A 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| 12/01/2010 | CN101903378A Aminotriazole derivatives |
| 12/01/2010 | CN101903377A 6H-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists |
| 12/01/2010 | CN101903375A Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
| 12/01/2010 | CN101903374A 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 12/01/2010 | CN101903372A Heteroaryl derivatives as orexin receptor antagonists |
| 12/01/2010 | CN101903371A Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide |
| 12/01/2010 | CN101903369A Leukotriene B4 inhibitors |
| 12/01/2010 | CN101903367A Antitumoral compounds |
| 12/01/2010 | CN101903365A Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting KSP kinesin activity |
| 12/01/2010 | CN101903362A Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists |
| 12/01/2010 | CN101903359A Triazole-substituted arylamide derivatives and their use as P2X3 and /or P2X2/3 purinergic receptor antagonists |
| 12/01/2010 | CN101903358A Perhydrochinoxalin-derivate |
| 12/01/2010 | CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors |
| 12/01/2010 | CN101903356A 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof |
| 12/01/2010 | CN101903355A Novel imidazole-substituted arylamides |
| 12/01/2010 | CN101903353A Aminopyrazole derivatives |
| 12/01/2010 | CN101903352A Substituted 3-hydroxypyridines and pharmaceutical compositions thereof |
| 12/01/2010 | CN101903351A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/01/2010 | CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators |
| 12/01/2010 | CN101903348A Novel pyrazole-substituted arylamides |
| 12/01/2010 | CN101903347A Piperidinyl and piperazinyl modulators of gamma-secretase |
| 12/01/2010 | CN101903343A Compounds for inhibiting KSP kinesin activity |
| 12/01/2010 | CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators |
| 12/01/2010 | CN101903341A Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 12/01/2010 | CN101903340A Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 12/01/2010 | CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 12/01/2010 | CN101903338A Phenyl acetic acid derivatives as inflammation modulators |
| 12/01/2010 | CN101903337A Antitumoral compounds |
| 12/01/2010 | CN101903335A Amine linked modulators of gamma-secretase |
| 12/01/2010 | CN101903045A Pharmaceutical composition for treatment of cataract |
| 12/01/2010 | CN101903028A Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| 12/01/2010 | CN101903027A Preventive or therapeutic agent for inflammatory bowel disease |
| 12/01/2010 | CN101903026A Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 12/01/2010 | CN101903025A Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors |
| 12/01/2010 | CN101903024A Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists |
| 12/01/2010 | CN101903023A P-menthawe-3-carboxylic acid esters to treat airways diseases |
| 12/01/2010 | CN101903022A Aqueous retinoid and benzoyl peroxide gel |
| 12/01/2010 | CN101903021A Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 12/01/2010 | CN101903020A L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same |
| 12/01/2010 | CN101903015A Active pharmaceutical ingredient on solid support, amorphous and with improved solubility |
| 12/01/2010 | CN101903010A Topical compositions comprising non-proteogenic amino acids and methods of treating skin |
| 12/01/2010 | CN101902927A Liquid edible composition comprising isoflavones |
| 12/01/2010 | CN101902914A Azolylmethyloxiranes, use thereof and agents containing the same |
| 12/01/2010 | CN101902913A Pre-surgical treatment |
| 12/01/2010 | CN101899485A Benazepril hydrochloride composition with effect of reducing blood pressure and preparation method thereof |
| 12/01/2010 | CN101899116A Non-invasive high-penetrability epidermal growth factor and application thereof |
| 12/01/2010 | CN101899082A Triterpenoid saponin compound, application and preparation method |
| 12/01/2010 | CN101899081A Synthetic method of glycyrrhetinic acid ester derivative and deoxyglycyrrhetinic acid ester compound |
| 12/01/2010 | CN101899078A Extraction method of glossy privet fruit glycoside and application of glossy privet fruit glycoside in preparation of medicament |
| 12/01/2010 | CN101899077A Extraction method and application of icariside I in Korean epimedium herb leaf |
| 12/01/2010 | CN101899076A Azithromycin derivative, preparation method and intermediate thereof |
| 12/01/2010 | CN101899074A Preparation method for monosialotetrahexosyl ganglioside and monosialotetrahexosyl ganglioside sodium injection or freeze-dried powder injection |
| 12/01/2010 | CN101899059A Pyrrolidine-containing dicyclic cephalosporin derivatives |
| 12/01/2010 | CN101899057A Preparation method of pyrimido-oxazole derivative and use thereof in medicine |
| 12/01/2010 | CN101899056A Prasugrel hydrobromide polymorph and preparation method thereof |
| 12/01/2010 | CN101899054A Antiatherosclerotic sparstolenin B compound and preparation method thereof |
| 12/01/2010 | CN101899053A C crystal form solid matter of bergenin and preparation method and application thereof |
| 12/01/2010 | CN101899052A B-crystal form solid matter of bergenin and preparation method and application thereof |
| 12/01/2010 | CN101899051A 1-azaxanthone-3-formamide compounds as well as preparation method and antitumor application thereof |
| 12/01/2010 | CN101899048A Salt of (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1- carboxylic acid methyl ester |
| 12/01/2010 | CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes |
| 12/01/2010 | CN101899045A 9-substituted-2-amino-6-guanidyl purine compounds as well as preparation method and application thereof |
| 12/01/2010 | CN101899043A Tylophora ovata base analogs with anti-tumor activity and preparation method and use thereof |
| 12/01/2010 | CN101899041A Superior medicinal crystal-form solid substance of puerarin as well as preparation method and application thereof |
| 12/01/2010 | CN101899028A New furanditerpenoid compound, preparation method and application thereof |
| 12/01/2010 | CN101899017A Benzsulfamide compound with function of inhibiting HIV-1 (Human Immunodeficiency Virus type 1) capsid protein, preparation method and application thereof |
| 12/01/2010 | CN101899013A 2-(2-substituted aryl-2H-1,2,4-triazole-3-sulfydryl) acetamide derivative and preparation method and application thereof |
| 12/01/2010 | CN101899011A Dithiocarbamates compound, preparation method and application thereof |
| 12/01/2010 | CN101899010A Quinazol derivative, preparation method and application thereof |
| 12/01/2010 | CN101899008A N-substituted pyrimidine sulfonyl-substituted benzamide type small molecular inhibitor for Bcl-2 protein and application thereof |
| 12/01/2010 | CN101899006A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |